Beta Bionics [BBNX] vs Boston Scientific [BSX] Detailed Stock Comparison

Beta Bionics

NASDAQ
Loading...

Boston Scientific

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Beta Bionics wins in 5 metrics, Boston Scientific wins in 12 metrics, with 0 ties. Boston Scientific appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricBeta BionicsBoston ScientificBetter
P/E Ratio (TTM)-17.4257.93Beta Bionics
Price-to-Book Ratio3.216.43Beta Bionics
Debt-to-Equity Ratio2.2253.09Beta Bionics
PEG Ratio3.900.40Boston Scientific
EV/EBITDA-11.8233.14Beta Bionics
Profit Margin (TTM)-94.04%13.55%Boston Scientific
Operating Margin (TTM)-85.52%18.63%Boston Scientific
EBITDA Margin (TTM)N/A18.63%N/A
Return on Equity22.32%11.55%Beta Bionics
Return on Assets (TTM)-36.59%5.39%Boston Scientific
Free Cash Flow (TTM)$-51.67M$2.37BBoston Scientific
1-Year Return-6.51%15.12%Boston Scientific
Price-to-Sales Ratio (TTM)12.407.80Boston Scientific
Enterprise Value$724.61M$155.93BBoston Scientific
EV/Revenue Ratio9.298.43Boston Scientific
Gross Profit Margin (TTM)53.80%67.65%Boston Scientific
Revenue per Share (TTM)$4$13Boston Scientific
Earnings per Share (Diluted)$-1.69$1.68Boston Scientific
Beta (Stock Volatility)N/A0.61N/A
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Beta Bionics vs Boston Scientific Stock Performance Analysis

Loading Price Chart...

Beta Bionics
Boston Scientific
Beta Bionics Stock Overview | Boston Scientific Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Beta Bionics-1.39%13.98%13.11%64.64%106.69%-5.80%
Boston Scientific-0.64%-0.88%-9.50%-6.71%-1.20%8.88%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Beta Bionics-6.51%-6.51%-6.51%-6.51%-6.51%-6.51%
Boston Scientific15.12%144.77%136.56%476.54%1,487.60%312.37%

News Based Sentiment: Beta Bionics vs Boston Scientific

Beta Bionics

News based Sentiment: POSITIVE

Beta Bionics demonstrated strong Q2 earnings, exceeding expectations, and secured a significant analyst upgrade. While insider selling is a concern, the influx of institutional investment and strategic partnership with Abbott suggest a positive trajectory for the company, making this a noteworthy month for investors.

View Beta Bionics News Sentiment Analysis

Boston Scientific

News based Sentiment: POSITIVE

October brought a wave of positive signals for Boston Scientific, including increased institutional investment, raised price targets from multiple firms, and a promising long-range plan. While insider selling remains a point to watch, the overall narrative is one of strong growth potential and investor confidence.

View Boston Scientific News Sentiment Analysis

Performance & Financial Health Analysis: Beta Bionics vs Boston Scientific

MetricBBNXBSX
Market Information
Market Cap i$1.10B$144.20B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i803,62312,773,240
90 Day Avg. Volume i938,15110,174,867
Last Close$21.95$96.70
52 Week Range$8.89 - $26.66$80.64 - $109.50
% from 52W High-17.67%-11.69%
All-Time High$26.66 (Sep 12, 2025)$109.50 (Sep 09, 2025)
% from All-Time High-17.67%-11.69%
Growth Metrics
Quarterly Revenue Growth0.54%0.23%
Quarterly Earnings Growth0.80%1.46%
Financial Health
Profit Margin (TTM) i-0.94%0.14%
Operating Margin (TTM) i-0.86%0.19%
Return on Equity (TTM) i0.22%0.12%
Debt to Equity (MRQ) i2.2253.09
Cash & Liquidity
Book Value per Share (MRQ)$6.94$15.14
Cash per Share (MRQ)$5.75$0.36
Operating Cash Flow (TTM) i$-57,461,000$4.28B
Levered Free Cash Flow (TTM) i$-54,756,000$2.94B
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Beta Bionics vs Boston Scientific

MetricBBNXBSX
Price Ratios
P/E Ratio (TTM) i-17.4257.93
Forward P/E i-12.3934.88
PEG Ratio i3.900.40
Price to Sales (TTM) i12.407.80
Price to Book (MRQ) i3.216.43
Market Capitalization
Market Capitalization i$1.10B$144.20B
Enterprise Value i$724.61M$155.93B
Enterprise Value Metrics
Enterprise to Revenue i9.298.43
Enterprise to EBITDA i-11.8233.14
Risk & Other Metrics
Beta iN/A0.61
Book Value per Share (MRQ) i$6.94$15.14

Financial Statements Comparison: Beta Bionics vs Boston Scientific

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)BBNXBSX
Revenue/Sales i$17.64M$4.66B
Cost of Goods Sold i$8.67M$1.45B
Gross Profit i$8.97M$3.21B
Research & Development i$7.59M$443.00M
Operating Income (EBIT) i$-18.64M$937.00M
EBITDA i$-5.59M$1.23B
Pre-Tax Income i$-28.66M$805.00M
Income Tax iN/A$133.00M
Net Income (Profit) i$-28.66M$672.00M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)BBNXBSX
Cash & Equivalents i$42.45M$725.00M
Total Current Assets i$261.92M$7.34B
Total Current Liabilities i$16.49M$5.06B
Long-Term Debt i$5.45M$10.93B
Total Shareholders Equity i$313.75M$22.45B
Retained Earnings i$-325.39M$3.35B
Property, Plant & Equipment i$13.04M$448.00M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)BBNXBSX
Operating Cash Flow i$-24.83M$513.00M
Capital Expenditures i$-333,000$-187.00M
Free Cash Flow i$-20.31M$277.00M
Debt Repayment iN/A$-1.31B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricBBNXBSX
Shares Short i3.88M19.02M
Short Ratio i5.522.76
Short % of Float i0.10%0.01%
Average Daily Volume (10 Day) i803,62312,773,240
Average Daily Volume (90 Day) i938,15110,174,867
Shares Outstanding i42.86M1.47B
Float Shares i21.42M1.48B
% Held by Insiders i0.01%0.00%
% Held by Institutions i1.09%0.94%

Dividend Analysis & Yield Comparison: Beta Bionics vs Boston Scientific

MetricBBNXBSX
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A